Profile
Yoram Azulai is currently the Chief Executive Officer, CFO & Secretary at HBL- Hadasit Bio-Holdings Ltd. He is also a Director at Zingenix Ltd. and Tolaren Ltd. Previously, he served as a Director at ProtAb Ltd.
Yoram Azulai active positions
| Companies | Position | Start |
|---|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Chief Executive Officer | 31/03/2020 |
Zingenix Ltd.
Zingenix Ltd. BiotechnologyHealth Technology Provides gene therapy for orphan disorders | Director/Board Member | - |
Tolaren Ltd. | Director/Board Member | - |
Former positions of Yoram Azulai
| Companies | Position | End |
|---|---|---|
ProtAb Ltd.
ProtAb Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents that modulate cytokine regulation and tipping the balance toward anti-inflammatory signaling pathways | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
HBL- Hadasit Bio-Holdings Ltd.
HBL- Hadasit Bio-Holdings Ltd. Investment ManagersFinance Provides investment services in research and development companies for the medical & biotechnology sectors | Finance |
ProtAb Ltd.
ProtAb Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents that modulate cytokine regulation and tipping the balance toward anti-inflammatory signaling pathways | Health Technology |
Zingenix Ltd.
Zingenix Ltd. BiotechnologyHealth Technology Provides gene therapy for orphan disorders | Health Technology |
Tolaren Ltd. |
- Stock Market
- Insiders
- Yoram Azulai
















